Double-blind placebo-controlled comparative study for the efficacy of treatment on the patient with NERD between omeprasole versus omeprasole plus mosapride citrate

Double-blind placebo-controlled comparative study for the efficacy of treatment on the patient with NERD between omeprasole versus omeprasole plus mosapride citrate - Treatment of NERD Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000000927

Enrollment

200

Registered

2007-12-10

Start date

2007-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NERD (non-erosive reflux disease)

Interventions

ome

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: non

Exclusion criteria

Exclusion criteria: non

Design outcomes

Primary

Measure	Time frame
Ratio of the patients with none or minimal symptoms	—

Secondary

Measure	Time frame
1. Mean of VAS score 2. GSRS Score	—

Countries

Japan

Contacts

Public ContactHiroto Miwa

Hyogo College of Medicine Department of Internal Medicine Division of Upper Gastroenterology

miwa-sec@hyo-med.ac.jp0798-45-6665

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026